Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550484 · ClinicalTrials.gov registry record · Phase 2
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
A Phase 2 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT01550484 is a Phase 2 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 170 participants.
The verdict
NCT01550484, a Phase 2 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether 18F-AV-133 PET scans can be used to differentiate subjects with Parkinson's Disease from other movement disorders.
Interventions
- DRUG 18F-AV-133
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01550484
The ClinicalTrials.gov registry entry for NCT01550484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-AV-133 is the first listed.
NCT01550484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01550484 about?
NCT01550484 is a clinical study titled "A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders". The purpose of this study is to determine whether 18F-AV-133 PET scans can be used to differentiate subjects with Parkinson's Disease from other movement disorders.
What is the current status of trial NCT01550484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2012-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01550484?
The interventions under investigation include: 18F-AV-133 (DRUG).
Who is sponsoring clinical trial NCT01550484?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.